News
Refined Metals Corp. and Eagle Plains Resources Enter into an Option Agreement for the Dufferin Project in the Athabasca Basin
6,424 hectare Dufferin Project located approximately 130km northwest of the Key Lake Mines, Saskatchewan
Vancouver, British Columbia, February 27, 2024 – Refined Metals Corp. (CSE: RMC;
bluebird bio: How to play LEAPS options for growth and income
Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG
Quad/Graphics is a benefactor of the advertising rebound
Quad/Graphics Inc. (NYSE: QUAD) is a global full-service marketing solutions firm for commercial clients in the retail, healthcare, financial services, publishing and consumer packaging
Welchau Gas Exploration Well Update
- Drilling Operations Report No 1
Vancouver, British Columbia – February 27, 2024 – MCF Energy Ltd. (TSX.V: MCF; FRA: DC6; OTCQX: MCFNF) (“MCF”, “MCF Energy” or the “Company”) is
Thinking long-term? Don't lose interest in Pinterest
Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst
Refined Metals Corp. and Eagle Plains Resources Enter into an Option Agreement for the Dufferin Project in the Athabasca Basin
6,424 hectare Dufferin Project located approximately 130km northwest of the Key Lake Mines, Saskatchewan
Vancouver, British Columbia, February 27, 2024 – Refined Metals Corp. (CSE: RMC;
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Most hype surrounds technology stocks, particularly after the king of the sector, Nvidia Corp. (NASDAQ: NVDA), kept breaking past all-time high prices on ever-increasing financial expansion. There
Nvidia and S&P 500 rallies: Cracks in the armor?
Nvidia Corp.’s (NASDAQ: NVDA) 59% gain since the start of 2024 has propelled the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) and the Invesco QQQ (NASDAQ: QQQ) to new highs.
In particular, Nvidia is
Live Nation stock rides the pent-up demand for live events
Live Nation Entertainment Inc. (NYSE: LYV) is the global leader in live music and entertainment events. Live Nation has tremendous scale with a rock-solid moat as it promoted over 50,000 live
bluebird bio stock is ripe for a 400% institutional short squeeze
Maybe you are looking back at the 2020-2023 equity curve in your portfolio and are noticing an increasingly slowing upward trend. This is not your fault but rather the effects of the Federal
Medaro Mining Unveils Promising Findings from Satellite Survey at its Lac La Motte Lithium Project
Vancouver, British Columbia – February 27, 2024 – Medaro Mining Corp. (CSE: MEDA) (“Medaro” or the “Company”) is pleased to announce the completion of its nuclear magnetic resonance (NMR)
Myriad Uranium Announces Addition of Highly Prospective Target Area Revealed by Historic Data Trove, Increases Wyoming Land Position by 41%
Vancouver, B.C. – February 26, 2024 – Myriad Uranium Corp. (“Myriad” or the “Company”) (CSE: M, OTC: MYRUF, FRA: C3Q) is pleased to announce the staking of the Knob claims, a significant
Patriot Announces Additional 2023 Drill Results at CV13 and Provides Infrastructure Development Update, Corvette, Quebec, Canada
Highlights
- Patriot continues to intersect spodumene at the CV13 Pegmatite, with highlights:
- 22.5 m at 1.10% Li2O, including 15.2 m at 1.57% Li2O (CV23-300).
- 19.4 m at 1.20%
These 2 carnivore dining stocks gaining on the Ozempic craze
The Ozempic and GLP-1 weight loss trend parallels the artificial intelligence (AI) mania that's gone mainstream viral, sending stocks like Novo Nordisk A/S (NYSE: NVO) and Nvidia Corp. (NASDAQ:
This infrastructure construction stock: Is it ready to pop?
As everyone focuses on technology stocks and artificial intelligence hype, names like Nvidia Corp. (NASDAQ: NVDA) keep beating expectations and breaking past all-time high prices. You can focus on
Is The Trade Desk signaling the rebound of digital advertising?
The Trade Desk Inc. (NASDAQ: TTD) is a leading independent programmatic advertising technology (AdTech) platform provider. Its demand-side platform (DSP) allows companies to automate their digital
Is Roku worth a second look after the earnings panic selloff?
Streaming video hardware and software platform operator Roku Inc. (NASDAQ: ROKU) shares plummeted over 35% following its Q4 2023 earnings report. The company generates most revenues from its
Domino’s stock or Papa John’s? Follow price action to find out
Most of the market is now focused on the hype in the high-flying technology stocks today, where names like NVIDIA (NASDAQ: NVDA) keep delivering insane financial results to help the stock break
This healthcare stock making a buzz with 160% growth
Investing in healthcare stocks may not seem very exciting. This group of low-beta stocks serves as a defensive area of the consumer staples sector without much growth or activity. That is, of
Karora Resources Drills 13.7% Ni over 2.6 metres,12.0% Ni over 2.9 metres, and 15.4% Ni over 0.6 Metres Further Demonstrating the High-Grade Potential of the Open-Ended 50C Nickel Trough
TORONTO, February 26, 2024 – Karora Resources Inc. (TSX:KRR; OTCQX:KRRGF) ("Karora" or the “Corporation") - https://www.commodity-tv.com/ondemand/companies/profil/karora-resou
MCF Energy Acquires Accretive Czech Gas Projects with Immediate Production and Growth Potential
Vancouver, British Columbia – February 26, 2024 – MCF Energy Ltd. (TSX.V: MCF; FRA: DC6; OTCQX: MCFNF) (“MCF”, “MCF Energy” or the “Company”) is pleased to announce its agreement to acquire
First it was Tyson stock, now this food company is set to rally
During the past quarter, some news has hit the agricultural industry to help the businesses that operate within it and take some of the inflationary pressure off of the American consumer. The
Is CRISPR Therapeutics the NVIDIA of gene editing?
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approval for a gene-editing therapy for